Skip to main content
Livermore
Livermore
ZHEN

Discovery Value Fund

SEC CIK
0001750451
Latest filing
Aug 10, 2026

NTLA holding history

Intellia Therapeutics, Inc. in every 13F filed by Discovery Value Fund, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NTLA overviewAll 13F holders of NTLAFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of NTLA by Discovery Value Fund, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−97,976−100.0%Sold outHolders
Q4 202597,976$880.8K2.3%−130,725−57.2%ReducedHolders
Q3 2025228,701$3.95M7.1%00.0%UnchangedHolders
Q2 2025228,701$2.15M4.2%−332,860−59.3%ReducedHolders
Q1 2025561,561$3.99M5.7%00.0%UnchangedHolders
Q4 2024561,561$6.55M3.8%00.0%UnchangedHolders
Q3 2024561,561$11.5M5.9%00.0%UnchangedHolders
Q2 2024561,561$12.6M6.4%00.0%UnchangedHolders
Q1 2024561,561$15.4M5.4%00.0%UnchangedHolders
Q4 2023561,561$17.1M7.8%00.0%UnchangedHolders
Q3 2023561,561$17.8M9.7%00.0%UnchangedHolders
Q2 2023561,561$22.9M11.6%00.0%UnchangedHolders
Q1 2023561,561$20.9M10.5%−11,389−2.0%ReducedHolders
Q4 2022572,950$20.0M5.8%−11,533−2.0%ReducedHolders
Q3 2022584,483$32.7M8.2%00.0%UnchangedHolders
Q2 2022584,483$30.3M6.3%−401,690−40.7%ReducedHolders
Q1 2022986,173$71.7M5.3%−4,579−0.5%ReducedHolders
Q4 2021990,752$117.1M4.3%+68,341+7.4%AddedHolders
Q3 2021922,411$123.7M3.6%−7,258−0.8%ReducedHolders
Q2 2021929,669$150.5M4.1%+783,179+534.6%AddedHolders
Q1 2021146,490$11.8M0.4%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.